Melanie Matheu, Founder and CEO of Prellis Biologics.
Dr. Matheu founded Prellis Biologics in October 2016 with a design for an laser-based non-cell toxic printing system on paper and a vision to create fully vascularized human tissues and organs for transplantation. Her realization that the tiny blood vessels necessary for creating human organs could be replicated using the technology at the center of her research, led to development of the blended engineering and biology approach Prellis is using to solve the human organ shortage.
Prellis Biologics, Inc has demonstrated the fastest high resolution 3D printing speeds to date, making for the first time in history of human tissue engineering building transplantable organs possible.